{"disease":{"id":"cystic-fibrosis-of-pancreas","name":"cystic fibrosis of pancreas"},"drugs":{"marketed":[{"drug_id":"vitamin-k1","indication_name":"Hypoprothrombinemia secondary to cystic fibrosis of the pancreas","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vitamin K1","generic_name":"Phytonadione","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Vitamin K-dependent carboxylase; vitamin K epoxide reductase complex (indirect antagonism of warfarin effects)","drug_class":"Vitamin K [EPC]","quality_score":55,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06084468","title":"Cardiac Structure and Function in Patients with Cystic Fibrosis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":104,"lead_sponsor_name":"Herlev and Gentofte Hospital","has_results":false},{"nct_id":"NCT03264950","title":"Utility of Point Shear-wave Elastography to Assess for Hepatic & Pancreatic Fibrosis in Pediatric CF Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"University of Manitoba","has_results":false},{"nct_id":"NCT04302662","title":"Phase 2 Combination Study With Escalating Doses of MS1819-SD on Top of a Stable Dose of PPEs","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"AzurRx SAS","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}